ClinicalTrials.gg
RecruitingNCT07482800Updated Mar 20, 2026

Dementia in Fiction and Clinical Narratives

An observational study in Dementia and Alzheimer s Disease, sponsored by Fu Jen Catholic University. Recruiting at 1 site in Taiwan. Open to participants aged 60 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-20.

Sponsored by Fu Jen Catholic University · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2026, 3 months ago, but the record still lists the study as recruiting.
  • Started Mar 2026; still recruiting 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
40
Ages
60 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 105 studies in Dementia with a site in Taiwan — 23 open to participants now, 28 under way, 1 of them phase 3. Dementia · Taiwan.

Planned enrollment
17th of 20
40 · median 225
Started
2026
with 7 others
Observational
20 of 105
7 open now
Primary completion
2026-07
later than 9 of 27 live
Registered
99th of 105
by date

Among the 105 studies in Dementia with a site in Taiwan, this one is the 17th largest by planned enrollment of the 20 observational ones that give a count, is one of 8 that started in 2026, is one of 20 observational ones, reaches primary completion later than 9 of the 27 other live ones, and was the 99th registered.

Dementia

2,377 studies on the registry are indexed under Dementia; 572 are open to participants now.

Browse Dementia studies →

Open to participants now

23 of the 105 studies in Dementia with a site in Taiwan are open now. Recruiting first, the newest first:

17 more — sign in →

All 23 open studies →

A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →

Who these studies take

Of the 382 Dementia studies recruiting now, 242 (63%) set no upper age limit and 25 (7%) stop at 75 or younger; 15 take children under 18; 163 take healthy volunteers.

This study: 60 Years to 85 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 105 studies in Dementia with a site in Taiwan, or all of them as a file.
02

Study summary

This study aims to compare the natural narrative language of patients with Alzheimer's disease and the fictional depictions of dementia in contemporary novels from both neurological and literary perspectives. It investigates the similarities and differences in the deterioration of semantic and episodic memory. The goal is to develop a cross-disciplinary language observation model that enhances early diagnostic understanding, fosters empathy in caregiving, and strengthens medical humanities education.

Read the detailed description

Background: Dementia is a major neurodegenerative disease of concern in aging societies worldwide, with Alzheimer's disease being the most common form. Early symptoms often involve language impairments and narrative disorganization. While neurology has extensively studied semantic memory and pragmatic dysfunction, systematic analysis of natural language narratives remains limited. Meanwhile, contemporary "neuronovels" depict the linguistic and cognitive decline of characters with dementia in highly realistic and emotionally resonant ways, providing narrative insights that may complement clinical observations. This project uses novels such as The Tunnel by A. B. Yehoshua and Still Alice by Lisa Genova as key texts, integrating real patient data and neurobehavioral assessments to construct a model that bridges clinical and literary approaches.

Study Design: This is a one-year prospective study.

Methods: Semi-structured interviews will be conducted to collect spontaneous narratives focusing on childhood memories, life events, and self-description. Audio recordings will be transcribed and analyzed for linguistic features and behaviors. In parallel, fictional narratives from selected dementia-themed novels will be analyzed for language disruption, narrative fragmentation, and identity construction in characters with dementia. A multidisciplinary team will conduct cross-comparative analyses between clinical data and literary texts to establish a reference framework of language decline and narrative behavior for future diagnostic support and empathy training.

03

Conditions studied

  • Dementia
  • Alzheimer s Disease

Keywords

  • Dementia
  • Language Decline
  • Neurology
  • Narrative Medicine
  • Literary Analysis
04

Who can participate

Ages eligible
60 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

patient of affiliated university hospital

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosed with early-stage Alzheimer's disease or other mild cognitive impairment by a neurologist (case group) / healthy individuals matched for age and education level (control group)
  • Able to communicate and understand basic language

Exclusion criteria

Exclusion Criteria:

  • Refuse to participate in the study
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
40 participants (estimated)
Patient registry
No

Groups and cohorts

  • Case group

    Diagnosed with early-stage Alzheimer's disease or other mild cognitive impairment by a neurologist

  • Control group

    Healthy individuals matched for age and education level

06

What researchers measure

Primary outcomes

  1. Mini-Mental State Examination

    assess cognitive function, including orientation, memory, attention, language, and basic visuospatial ability

    Time frame: on the day of enrollment

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Jul 2026, 4 months after the start.

Of 272 non-industry observational studies under Dementia, half reached primary completion within 74 months of starting (the median), counting those still running; a quarter within 32 and three quarters within 202. This study's planned 4 months is below that.

Counting every sponsor, half of 294 studies reached it within 65 months; a quarter within 29 and three quarters within 188.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 8, 2026
First posted
Mar 19, 2026
StartActual
Mar 17, 2026
Primary completionEst.
Jul 31, 2026
CompletionEst.
Jul 31, 2026
Last update
Mar 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07482800
Lead sponsor
Fu Jen Catholic University
Responsible party
Ke-Yun, Chao (Assistant Professor, Fu Jen Catholic University) — Principal investigator
First posted
Mar 19, 2026
Start date
Mar 17, 2026
Primary completion
Jul 31, 2026 (estimated)
Completion
Jul 31, 2026 (estimated)
Last update
Mar 20, 2026

Study contacts

Ke-Yun Chao, PhD
Contact
ck_qq@hotmail.com
+886-905-301-879
Ke-Yun Chao, PhD
principal investigator · Fu Jen Catholic University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion